BACARDI-LIMITED
30.3.2021 13:02:15 CEST | Business Wire | Press release
After decades spent carefully building sustainable partnerships with farmers and suppliers, BOMBAY SAPPHIRE, the iconic premium gin from family-owned Bacardi Limited, is proud to announce that all 10 of its botanical ingredients are on track to be certified sustainable in 2021. With the suppliers of eight already certified according to the For Life standard, the goal is for the remaining two producers – for grains of paradise from Ghana and liquorice from China – to be certified in the months which follow the lifting of travel restrictions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210330005556/en/
This news is a major step towards Bacardi, the largest privately-held spirits company in the world, achieving its 2025 goal of sourcing 100% of its key ingredients from sustainably certified suppliers.
The 10 botanicals, which include juniper from Tuscany, coriander from Morocco, lemon peel from Spain and cubeb berries from Java, are hand selected by BOMBAY SAPPHIRE Master of Botanicals Ivano Tonutti to create the gin’s fresh, bright taste.
Only the finest quality botanicals are selected by Ivano and his work does not end there. The For Life certification awarded by Ecocert S.A., the world’s leading specialist in the certification of sustainable practices, recognizes the commitment of Ivano and Bacardi to only work with suppliers who act responsibly and ensure a sustainable future for farmers, their communities and the environment.
BOMBAY SAPPHIRE has pioneered sustainability in the spirits industry. The brand has long invested in new innovations offering creative solutions to complex challenges. When the BOMBAY SAPPHIRE distillery opened in Laverstoke, England, in 2014 it set a new standard for sustainability by showcasing many such innovations – the distillery’s design was rated ‘outstanding’ by BREEAM , the most recognized environmental assessment for buildings.
“We take a 360-degree approach to sustainability,” says Ivano Tonutti. ”It’s our responsibility to care as much about the farmers and their communities as we do the botanicals they grow and harvest for BOMBAY SAPPHIRE. By looking after their well-being and investing in sustainable farming practices, we are helping to protect the environment and their livelihoods for generations to come.”
An example of this in practice is the village in Ghana where, over a number of years, Bacardi has worked with AIESEC, a local non-governmental organization, to help the community establish itself as an independent farming cooperative – from installing a water pump, which now supplies the village with fresh water, to recruiting an agronomist for expert advice and guidance. This year, the village will harvest its first crop of grains of paradise for BOMBAY SAPPHIRE.
“For Life certification gives consumers peace of mind that ingredients are coming from organizations committed to continuous improvement,” says Ecocert CEO Philippe Thomazo. “For Life means that suppliers growing and harvesting the certified botanicals for BOMBAY SAPPHIRE are acting responsibly in every respect.”
Natasha Curtin, VP BOMBAY SAPPHIRE, says: “I am incredibly proud of this latest achievement by Ivano and his team but as an industry, we must all invest in a more sustainable future. Ivano has spent more than 20 years building close relationships with our farmers and suppliers around the world. With his experience and expertise, we have created a blueprint for the sustainable sourcing of botanicals, which we hope will inspire others to do the same.”
Bacardi worked closely with its suppliers to help them achieve For Life certification. To be certified, suppliers must commit to continuous improvement in the following areas:
- the well-being of the people involved in the harvesting and supply of the botanicals;
- the reduction of their environmental impact;
- their responsible purchasing practices;
- and sustainable development at a local level and key stages in the supply chain.
Find out more about the sustainability commitments of Bacardi and its vision to become the most environmentally responsible global spirits company at https://www.bacardilimited.com/corporate-responsibility/environment/ .
Always drink responsibly.
About BOMBAY SAPPHIRE gin
BOMBAY SAPPHIRE, the world's number one premium gin, is created with a unique combination of 10 botanical ingredients sourced from around the globe. In the historic still houses of the BOMBAY SAPPHIRE distillery in Hampshire, England, spirit vapour passes through perforated copper baskets filled by hand with the 10 botanicals. Through this signature distillation process, called vapour infusion
, BOMBAY SAPPHIRE perfectly captures the natural, aromatic flavors of each botanical which results in the gin's fresh, bright taste. Awarded a double gold medal in the 2017 San Francisco World Spirits Competition, BOMBAY SAPPHIRE is consistently recognized for crafting the finest quality gin. For more information, please explore www.bombaysapphire.com
.
BOMBAY SAPPHIRE is part of the portfolio of Bacardi Limited, with global headquarters in Hamilton, Bermuda. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited.
About Bacardi Limited
Bacardi Limited, the largest privately held spirits company in the world, produces and markets internationally recognized spirits and wines. The Bacardi Limited brand portfolio comprises more than 200 brands and labels, including BACARDÍ® rum, GREY GOOSE® vodka, PATRÓN® tequila, DEWAR’S® Blended Scotch whisky, BOMBAY SAPPHIRE® gin, MARTINI® vermouth and sparkling wines, CAZADORES® 100% blue agave tequila, and other leading and emerging brands including WILLIAM LAWSON’S® Scotch whisky, ST-GERMAIN® elderflower liqueur, and ERISTOFF® vodka. Founded nearly 160 years ago in Santiago de Cuba, family-owned Bacardi Limited currently employs more than 7,000, operates production facilities in 11 countries, and sells its brands in more than 170 countries. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited. Visit www.bacardilimited.com
or follow us on Twitter
, LinkedIn
or Instagram
.
About Ecocert Group
With over 30 years of commitment to sustainability and to the development of organic farming worldwide, Ecocert provides stakeholders with support in understanding, implementing and promoting sustainable practices through training, consulting and independent certification services. Ecocert only offers a range of selected, recognized, and demanding standards with high environmental and societal criteria. For organizations willing to go further in the transition, Ecocert also develops innovative programs with higher requirements (Fair For Life, For Life, En Cuisine, etc.). Today the group is also a world leading company in the certification of organic agriculture and cosmetic, present in more than 130 countries through an international network of 31 subsidiaries with over 1,700 collaborators. To find out more on how Ecocert acts for a sustainable world, please visit: www.ecocert.com
or follow Ecocert on LinkedIn
or Facebook
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210330005556/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
